Sale!

Methylenetetrahydrofolate Reductase MTHFR Factor V F5 Factor II F2 Test Cost

Original price was: 3,200 د.إ.Current price is: 2,400 د.إ.

-25%

The Methylenetetrahydrofolate Reductase (MTHFR), Factor V (F5), and Factor II (F2) test is a comprehensive genetic assessment conducted at DNA Labs UAE. Priced at 2400 AED, this test is designed to identify mutations in the MTHFR gene and to screen for genetic variations in the Factor V and Factor II genes, which are crucial for understanding an individual’s risk of developing blood clot disorders and certain types of cardiovascular diseases.

The MTHFR gene plays a significant role in processing amino acids, which are the building blocks of proteins. A mutation in this gene can lead to elevated levels of homocysteine in the blood, a risk factor for heart disease, stroke, and other health issues. The Factor V Leiden mutation (related to the F5 gene) and the prothrombin G20210A mutation (related to the F2 gene) are both linked to an increased risk of developing harmful blood clots. Identifying these genetic variations can help in the early detection and management of associated health risks.

Performed at the state-of-the-art facilities of DNA Labs UAE, this test involves a simple blood draw. The results not only provide valuable insights into an individual’s genetic predisposition to certain conditions but also assist healthcare providers in developing personalized treatment and prevention strategies.

Description

Methylenetetrahydrofolate Reductase MTHFR FACTOR V F5 FACTOR II F2 Test

Test Name: Methylenetetrahydrofolate Reductase MTHFR FACTOR V F5 FACTOR II F2 Test

Components: EDTA Vacutainer (2ml)

Price: 2400.0 AED

Sample Condition: Peripheral blood

Report Delivery: 3-4 days

Method: End Point PCR + RFLP

Test Type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information: Methylenetetrahydrofolate Reductase (MTHFR), FACTOR V (F5), FACTOR II (F2) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

Methylenetetrahydrofolate Reductase (MTHFR) is an enzyme that is involved in the metabolism of folate, a B vitamin. Mutations in the MTHFR gene can lead to reduced activity of the enzyme, which can result in elevated levels of homocysteine in the blood. Elevated homocysteine levels have been associated with an increased risk of cardiovascular disease, stroke, and other health conditions.

Factor V (F5) is a protein that plays a role in blood clotting. Mutations in the F5 gene can lead to an increased risk of developing abnormal blood clots, a condition known as venous thromboembolism. The most common mutation associated with Factor V is called Factor V Leiden, which increases the risk of blood clots in veins.

Factor II (F2) is another protein involved in blood clotting. Mutations in the F2 gene can lead to an increased risk of developing abnormal blood clots, similar to Factor V mutations. The most common mutation associated with Factor II is called the prothrombin G20210A mutation, which increases the risk of blood clots in veins.

Testing for mutations in the MTHFR, F5, and F2 genes can be done to identify individuals who may be at increased risk for certain health conditions, such as cardiovascular disease or venous thromboembolism. This information can be used to guide treatment decisions and preventive measures.

Test Name	Methylenetetrahydrofolate Reductase MTHFR FACTOR V F5 FACTOR II F2 Test
Components	EDTA Vacutainer (2ml)
Price	2400.0 AED
Sample Condition	Peripheral blood
Report Delivery	3-4 days
Method	End Point PCR + RFLP
Test type	Genetics
Doctor	Oncology
Test Department:
Pre Test Information	Methylenetetrahydrofolate Reductase (MTHFR), FACTOR V (F5), FACTOR II (F2) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details	Methylenetetrahydrofolate Reductase (MTHFR) is an enzyme that is involved in the metabolism of folate, a B vitamin. Mutations in the MTHFR gene can lead to reduced activity of the enzyme, which can result in elevated levels of homocysteine in the blood. Elevated homocysteine levels have been associated with an increased risk of cardiovascular disease, stroke, and other health conditions. Factor V (F5) is a protein that plays a role in blood clotting. Mutations in the F5 gene can lead to an increased risk of developing abnormal blood clots, a condition known as venous thromboembolism. The most common mutation associated with Factor V is called Factor V Leiden, which increases the risk of blood clots in veins. Factor II (F2) is another protein involved in blood clotting. Mutations in the F2 gene can lead to an increased risk of developing abnormal blood clots, similar to Factor V mutations. The most common mutation associated with Factor II is called the prothrombin G20210A mutation, which increases the risk of blood clots in veins. Testing for mutations in the MTHFR, F5, and F2 genes can be done to identify individuals who may be at increased risk for certain health conditions, such as cardiovascular disease or venous thromboembolism. This information can be used to guide treatment decisions and preventive measures.